⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3792 | 0.67 | — | — | |
| SCHEMBL213833 | 0.55 | — | — | |
| SCHEMBL3707 | 0.52 | — | — | |
| SCHEMBL236463 | 0.50 | — | — | |
| SCHEMBL236440 | 0.50 | — | — | |
| SCHEMBL1042336 | 0.48 | — | — | |
| SCHEMBL129122 | 0.44 | — | — | |
| SCHEMBL2554291 | 0.44 | — | — | |
| SCHEMBL958835 | 0.38 | — | — | |
| SCHEMBL318855 | 0.35 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5824704-A | RETROVIRUSES; HUMAN IMMUNODEFICIENCY VIRUS | UNIROYAL CHEMICAL CO./CIE. (CA) | 1998-10-20 | — | — | US | claimed |
| US-5693827-A | Treatment of HIV infections and compounds useful therein | UNIROYAL CHEMICAL COMPANY, INC. | 1997-12-02 | — | — | US | claimed |
| US-5550280-A | INHIBITING GROWTH OR REPLICATION OF RETROVIRUSES SUCH AS HIV | UNIROYAL CHEMICAL LTD./ UNIROYAL CHEMICAL LTEE (CA) | 1996-08-27 | — | — | US | claimed |
| EP-0497816-B1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN | UNIROYAL CHEMICAL LTD (CA) | 1995-05-17 | — | — | EP | claimed |
| EP-0497816-A1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. | UNIROYAL CHEMICAL LTD (CA) | 1992-08-12 | — | — | EP | claimed |
| WO-1991005761-A1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN | UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) | 1991-05-02 | — | — | WO | claimed |
| US-5914351-A | Anti-viral aromatic hydrazones | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1999-06-22 | — | — | US | disclosed |
| US-5824704-A | RETROVIRUSES; HUMAN IMMUNODEFICIENCY VIRUS | UNIROYAL CHEMICAL CO./CIE. (CA) | 1998-10-20 | — | — | US | disclosed |
| US-5756813-A | TREATING RETROVIRUSES SUCH AS HUMAN IMMUNODEFICIENCY VIRUS | UNIROYAL CHEMICAL LTD/UNIROYAL CHEMICAL LTEE (CA) | 1998-05-26 | — | — | US | disclosed |
| US-5693827-A | Treatment of HIV infections and compounds useful therein | UNIROYAL CHEMICAL COMPANY, INC. | 1997-12-02 | — | — | US | disclosed |
| US-5663199-A | FOR TREATING HIV INFECTIONS | UNIROYAL CHEMICAL LTD./LTEE (CA) | 1997-09-02 | — | — | US | disclosed |
| US-5550280-A | INHIBITING GROWTH OR REPLICATION OF RETROVIRUSES SUCH AS HIV | UNIROYAL CHEMICAL LTD./ UNIROYAL CHEMICAL LTEE (CA) | 1996-08-27 | — | — | US | disclosed |
| EP-0497816-B1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN | UNIROYAL CHEMICAL LTD (CA) | 1995-05-17 | — | — | EP | disclosed |
| US-5268389-A | Containing a benzene ring | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1993-12-07 | — | — | US | disclosed |
| EP-0497816-A1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. | UNIROYAL CHEMICAL LTD (CA) | 1992-08-12 | — | — | EP | disclosed |
| WO-1991005761-A1 | TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN | UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) | 1991-05-02 | — | — | WO | disclosed |